Rapid reduction of adenomyosis coexisting with leiomyoma volume during treatment with Relugolix

• Main Authors: Keitaro Yamanaka (Author), Keiichi Washio (Author), Akiko Uchida (Author), Yuki Sasagawa (Author), Masashi Nishimoto (Author), Yui Yamasaki (Author), Satoshi Nagamata (Author), Yoshito Terai (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective This study elucidated the efficacy of Relugolix (REL) on the reduction of uterine volume and clinical symptoms for the treatment of adenomyosis.Methods We conducted a retrospective cohort study of patients who received REL (40 mg for about 20 weeks) and who underwent a hysterectomy for ade...